Analysis of exon dosage using MLPA in South African Parkinson's disease patients

Neurogenetics

Volumn 11, Issue 3, 2010, Pages 305-312

  Keyser, Rowena J ^a   Lombard, Debbie ^a   Veikondis, Rene ^b   Carr, Jonathan ^a   Bardien, Soraya ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

A Synuclein triplication; Exon dosage; MLPA; Parkin; Parkinson's disease; PINK1 Y258X

Indexed keywords

ALPHA SYNUCLEIN; DJ 1 PROTEIN; LEUCINE RICH REPEAT KINASE 2; PARKIN; UBIQUITIN PROTEIN LIGASE;

ADULT; ARTICLE; ATP13A2 GENE; CAV1 GENE; CAV2 GENE; CONTROLLED STUDY; ETHNIC GROUP; FALSE POSITIVE RESULT; FEMALE; GCH1 GENE; GENE; GENE DELETION; GENE DOSAGE; GENE FREQUENCY; GENE REARRANGEMENT; GENE REPLICATION; GENETIC ANALYSIS; HUMAN; LPA GENE; MAJOR CLINICAL STUDY; MALE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PARKINSON DISEASE; PINK1 GENE; POINT MUTATION; PRIORITY JOURNAL; SOUTH AFRICA; TNFRSF9 GENE; UCH L1 GENE; ADOLESCENT; AGED; DUPLICATE GENE; EXON; GENETICS; MIDDLE AGED; ONSET AGE; PEDIGREE; PREVALENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ALPHA-SYNUCLEIN; EXONS; FEMALE; GENE DOSAGE; GENE REARRANGEMENT; GENES, DUPLICATE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PEDIGREE; POINT MUTATION; PREVALENCE; SEQUENCE DELETION; SOUTH AFRICA; UBIQUITIN-PROTEIN LIGASES; YOUNG ADULT;

EID: 77954660828     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10048-009-0229-6     Document Type: Article

References (40)

1. Lesage S, Brice A (2009) Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 18(R1): R48-R59
2. Alves G, Forsaa EB, Pedersen KF, Dreetz Gjerstad M, Larsen JP (2008) Epidemiology of Parkinson's disease. J Neurol 255(Suppl 5):18-32
3. Hedrich K, Kann M, Lanthaler AJ, Dalski A, Eskelson C, Landt O et al (2001) The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. Hum Mol Genet 10(16):1649-1656
4. Hedrich K, Marder K, Harris J, Kann M, Lynch T, Meija-Santana H et al (2002) Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology 58(8):1239-1246
5. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S et al (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392(6676): 605-608 (Pubitemid 28207717)
6. Periquet M, Latouche M, Lohmann E, Rawal N, De Michele G, Ricard S (2003) French Parkinson's Disease Genetics Study Group; European Consortium on Genetic Susceptibility in Parkinson's Disease. Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain 126(Pt 6):1271-1278
7. Shadrina MI, Semenova EV, Slominsky PA, Bagyeva GH, Illarioshkin SN, Ivanova-Smolenskaia II, Limborska SA (2007) Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1-12 dosage. BMC Med Genet 26(8):6
8. Sun M, Latourelle JC, Wooten GF, Lew MF, Klein C, Shill HA et al (2006) Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Arch Neurol 63(6):826-832
9. Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S et al (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364(9440):1167-1169
10. Ibáñez P, Bonnet AM, Débarges B, Lohmann E, Tison F, Pollak P et al (2004) Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 364 (9440):1169-1171
11. Ross OA, Braithwaite AT, Skipper LM, Kachergus J, Hulihan MM, Middleton FA et al (2008) Genomic investigation of alphasynuclein multiplication and parkinsonism. Ann Neurol 63 (6):743-750
12. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J et al (2003) Alpha-synuclein locus triplication causes Parkinson's disease. Science 302(5646):841
13. Marongiu R, Brancati F, Antonini A, Ialongo T, Ceccarini C, Scarciolla O et al (2007) Whole gene deletion and splicing mutations expand the PINK1 genotypic spectrum. Hum Mutat 28 (1):98
14. Djarmati A, Hedrich K, Svetel M, Schäfer N, Juric V, Vukosavic S et al (2004) Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patients. Hum Mutat 23 (5):525
15. Djarmati A, Guzvic M, Grünewald A, Lang AE, Pramstaller PP, Simon DK et al (2007) Rapid and reliable detection of exon rearrangements in various movement disorders genes by multiplex ligation-dependent probe amplification. Mov Disord 22(12):1708-1714
16. Scarciolla O, Brancati F, Valente EM, Ferraris A, De Angelis MV, Valbonesi S et al (2007) Multiplex ligation-dependent probe amplification assay for simultaneous detection of Parkinson's disease gene rearrangements. Mov Disord 22(15):2274-2278
17. Gibb WRG, Lees AJ (1988) A comparison of clinical and pathological features of young-onset and old-onset Parkinson's disease. Neurology 38(9):1402-1406
18. Bardien S, Keyser RJ, Yako Y, Lombard D, Carr J (2009) Molecular analysis of the parkin gene in South African patients diagnosed with Parkinson's disease. Parkinsonism Relat Disord 15 (2):116-121
19. Hedrich K, Eskelson C, Wilmot B, Marder K, Harris J, Garrels J et al (2004) Distribution, type, and origin of Parkin mutations: review and case studies. Mov Disord 19(10):1146-1157
20. Ballabio A, Bardoni B, Guioli S, Basler E, Camerino G (1990) Two families of low-copy-number repeats are interspersed on Xp22.3: implications for the high frequency of deletions in this region. Genomics 8(2):263-270
21. Chen KS, Manian P, Koeuth T, Potocki L, Zhao Q, Chinault AC, Lee CC, Lupski JR (1997) Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome. Nat Genet 17(2):154-163
22. Yen PH, Li XM, Tsai SP, Johnson C, Mohandas T, Shapiro LJ (1990) Frequent deletions of the human X chromosome distal short arm result from recombination between low copy repetitive elements. Cell 61(4):603-610
23. Lee JA, Lupski JR et al (2006) Genomic rearrangements and gene copy-number alterations as a cause of nervous system disorders. Neuron 52(1):103-121
24. Hattori N, Kitada T, Matsumine H, Asakawa S, Yamamura Y, Yoshino H et al (1998) Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals. Ann Neurol 44 (6):935-941
25. Klein C, Lohmann-Hedrich K, Rogaeva E, Schlossmacher MG, Lang AE (2007) Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol 6(7):652-662
26. Brüggemann N, Mitterer M, Lanthaler AJ, Djarmati A, Hagenah J, Wiegers K et al (2009) Frequency of heterozygous Parkin mutations in healthy subjects: need for careful prospective followup examination of mutation carriers. Parkinsonism Relat Disord 15(6):425-429
27. Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M (2004) Comparison of kindreds with parkinsonism and alphasynuclein genomic multiplications. Ann Neurol 55(2):174-179
28. Ibáñez P, Lesage S, Janin S, Lohmann E, Durif F, Destée A et al (2009) Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms. Arch Neurol 66(1):102-108
29. Abeliovich A, Schmitz Y, Fariñas I, Choi-Lundberg D, Ho WH, Castillo PE et al (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25(1):239-252
30. Yavich L, Tanila H, Vepsäläinen S, Jäkälä P (2004) Role of alphasynuclein in presynaptic dopamine recruitment. J Neurosci 24 (49):11165-11170
31. Tan EK, Yew K, Chua E, Puvan K, Shen H, Lee E et al (2006) PINK1 mutations in sporadic early-onset Parkinson's disease. Mov Disord 21(6):789-793
32. Gandhi S, Muqit MM, Stanyer L, Healy DG, Abou-Sleiman PM, Hargreaves I et al (2006) PINK1 protein in normal human brain and Parkinson's disease. Brain 129(Pt7):1720-1731
33. Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH et al (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441(7097):1162-1166
34. Park J, Lee SB, Lee S, Kim Y, Song S, Kim S et al (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441(7097):1157-1161
35. Petit A, Kawarai T, Paitel E, Sanjo N, Maj M, Scheid M et al (2005) Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson diseaserelated mutations. J Biol Chem 280(40):34025-34032
36. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S et al (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304(5674):1158-1160
37. Bonifati V, Rohé CF, Breedveld GJ, Fabrizio E, De Mari M, Tassorelli C et al (2005) Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology 65(1):87-95
38. Klein C, Djarmati A, Hedrich K, Schäfer N, Scaglione C, Marchese R et al (2005) PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism. Eur J Hum Genet 13(9):1086-1093 (Pubitemid 43073617)
39. Rogaeva E, Johnson J, Lang AE, Gulick C, Gwinn-Hardy K, Kawarai T et al (2004) Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. Arch Neurol 61(12):1898-1904
40. Ephraty L, Porat O, Israeli D, Cohen OS, Tunkel O, Yael S, Hatano Y et al (2007) Neuropsychiatric and cognitive features in autosomal-recessive early parkinsonism due to PINK1 mutations. Mov Disord 15;22(4):566-569.